Treatment of Mania with Cinanserin, an Antiserotonin Agent
Abstract
Cinanserin, a new drug with antiserotonin activity, produced a rapid remission of the manic phase of manic-depressive psychosis in five of seven cases described by the author. No significant toxicity was encountered. The findings indicate that this drug deserves further clinical study.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).